Rocket


Overview
Financials
News + Filings

 
 

Kymera Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-19Dec-31-18
Revenues37.217.7
            Revenue growth110.2% 
Cost of goods sold71.435.4
Gross profit-34.2-17.7
            Gross margin-92.1%-100.0%
General and administrative8.03.8
EBIT-42.2-21.5
            EBIT margin-113.6%-121.3%
Pre-tax income-41.2-21.5
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-41.2-21.5
            Net margin-111.0%-121.4%
 
Diluted EPS($15.23)($11.45)
Shares outstanding (diluted)2.71.9
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy